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Abstract
Background: We developed an instrument assessing the extent of smoking cessation activities by general
practitioners (GPs) within the Cologne Smoking Study (CoSmoS). The objective of the present study was to
examine further psychometric quality of the “SmoCess-GP” instrument (Smoking Cessation by General
Practitioners).
Methods: 127 current smokers who had participated in the Cologne Smoking Study (CoSmoS) were included in
our analyses. Confirmatory factor analysis (CFA) was conducted to examine the model fit and to retest the single-
factor structure of the instrument using the Mplus software. Further construct validity was tested with bivariate
analysis using an instrument which measures patients’ trust in physicians.
Results: CFA supported the unidimensional structure of the instrument. The factor loadings exceed the threshold
of ≥ 0.50. All indicator reliabilities were higher than 0.30. The composite reliability was 0.86 and the average
variance extracted (AVE) resulted in a value of 0.50. The calculation of global fit indices identified a CFI value of
1.00 and for TLI a value of 1.02. The root mean square error of approximation (RMSEA) indicates that 0% of the
information is not accounted for by the model. The chi-square value was c
2
df = 6 = 4.63 (p = 0.59). Analysis of
discriminant validity resulted in a non-significiant correlation of r = 0.092 (p = 0.350).
Conclusions: Results indicate preliminary evidence for the construct validity of the “SmoCess-GP” instrument which
therefore appears to be a promising tool for analyzing the extent of smoking cessation advice offered by GPs from
the patients’ perspective. Future research should examine the psychometric properties in a population based
sample, further improvements of the instrument and should apply other methods of validation.
Background
In developed countries, smoking remains one of the
most significant and preventable risk factors for cardio-
vascular and lung diseases. In Germany, in particular,
approximately 37% of men and 28% of women smoke
every day or on occasion [1]. Similarly, data collected
within the European region as a whole demonstrate the
same smoking prevalence [2]. Despite widespread
knowledge of the risks and harmful consequences of
smoking, this prevalence has remained nearly constant
in Germany in recent years [3], whereas the smoking
prevalence trends of other countries vary [4-7]. Never-
theless, over one billion people smoke worldwide [8],
demonstrating the urgent need to increase and improve
efforts in smoking prevention and cessation.
General practitioners (GPs) play a major role in the
secondary prevention of smoking [9]. Acting as a so-
called “gatekeeper,” a GP has an intensive and, for the
most part, long-term relationship with his patients. In
large populations, it is a general practice that serves as a
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any medium, provided the original work is properly cited.patient’s first point of contact with the overall health
care system. Therefore, this setting provides an effective
means of accessing preventive care. Moreover, many
smokers visit a GP on an annual basis, giving GPs the
opportunity to promote smoking cessation interventions.
For these reasons, general practice seems to be a pro-
mising setting for the implementation of professional
preventive care.
According to German law, an important task of health
care professionals - especially of GPs - is preventive care
[10]. GPs should observe the law by providing patients
with professional support. Such support includes
attempts made to initiate, aid and sustain the efforts of
their patients to be more health conscious [11], espe-
cially when it comes to quitting smoking.
Although special treatments for smoking cessation
have increased in recent years [9] and the smoking pre-
vention efforts of GPs have been proven effective
[12-14], studies have shown that in various countries
there is still only a small number of GPs who provide
cessation advice to their patients during routine consul-
tations [12,15,16]. The same holds true in Germany
[17,18].
In Germany in particular, however, there is a lack of
data concerning the extent and effectiveness of GPs’
smoking cessation activities. According to Pfaff et al.
[19], such data are necessary in order to describe and
explain the professional care provided and in the next
step to encourage and improve smoking cessation inter-
ventions. Following a systematic Medline search in
March 2008, we identified only few validated instru-
ments for collecting these data from the patients’ per-
spective. For this reason, we designed a questionnaire
within the context of the Cologne Smoking Study (CoS-
moS). The present study evaluates the unidimensional
structure of the “SmoCess-GP” (Smoking Cessation by
General Practitioners) instrument which could be found
in a previous study [20] and to examine its further psy-
chometric quality. The study makes first efforts toward
confirming construct validity of the instrument with
global and local fit indices using confirmatory factor
analysis and it investigates its discriminant vailidity.
Methods
Measures
The “SmoCess-GP” measure
The “SmoCess-GP” instrument was carefully developed
within the context of the CoSmoS study, a case-control
study that examines which genetic and/or psychosocial
factors lead to a higher risk for smokers to suffer from
myocardial infarction, develop lung cancer and/or
become addicted to nicotine.
In order to ensure content validity, internal consis-
tency and the assessment of practice-relevant dimen-
sions, the “SmoCess-GP” instrument was developed
based on recognized international and German guide-
lines for the professional treatment of smoking depen-
dence [13,21,22]. Brief interventions recommended for
use by GPs in these guidelines were included as items
in the instrument (see Table 1). “SmoCess-GP” retro-
spectively measures whether a particular intervention
was undertaken by the treating GP. Based on cognitive
pretests with a sample which consisted of n = 10 lung
cancer patients, n = 10 myocardial infarction patients
and n = 20 individuals from the general population of
patients, the resulting “SmoCess-GP” instrument com-
prised six items (see Table 1) and had a dichotomous
response format ("yes” =1o r“no” = 0). Participants
were also given the option of responding with “Id o
not consult a practitioner.” Participants, who could not
remember if their GPs had provided them with a
smoking cessation intervention, could respond with “I
don’t know”.
An initial psychometric evaluation of the instrument
was conducted using exploratory factor and reliability
analysis as discussed in a previous study [20]. In sum-
mary, the findings in this study provided first indica-
t i o n so ft h em e a s u r eb e i n gar e l i a b l ea n dv a l i d
instrument with an acceptable Cronbach’sa l p h ao f. 6 8
[23].
Table 1 Items of the “SmoCess-GP"- instrument and descriptive statistics (n = 127)
Item Missing
values
yes no
n% n %
1. My practitioner
1 frequently asked me how many cigarettes I smoke per day. 1 89 70.6 37 29.4
2. My practitioner frequently cautioned me about the negative consequences of smoking. 0 78 61.4 49 38.6
3. My practitioner empathically demanded me to quit smoking. 0 66 52 61 48
4. My practitioner recommended a smoking cessation course. 1 18 14.3 108 85.7
5. My practitioner gave me behavioral advice about quitting. 2 17 13.6 108 86.4
6. My practitioner prescribed me/advised me to undergo a nicotine replacement therapy (e.g., transdermal
patches, nicotine solution drops, nicotine gum).
0 22 17.3 105 82.7
1 The participants were asked to respond with regards to the practitioner they contact first if they have a health problem (e.g., their general practitioner).
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With regard to construct validity, especially in order to
examine convergent validity, within the context of CoS-
moS it was not possible to integrate another, similar
instrument for assessing smoking cessation activities by
physicians. Therefore, as an example, the Health Plan
Employer Data and Information Set (HEDIS) measure
“Medical Assistance with Smoking Cessation” [24]
would have been feasible. Thus, we approached the dis-
criminant validity by analyzing the relationship of the
“SmoCess-GP” instrument with the evaluation of the
patients’ trust in their GPs to ensure the measurement
of different constructs. We used this variable because -
in addition to “SmoCess-GP” - it also evaluates aspects
of care by the patients’ GPs. The construct was surveyed
using the “trust in physicians_short form” scale of the
Cologne-Patient-Questionnaire (CPQ) [25], which was
developed and has been used in several research projects
and studies carried out by the Institute for Medical
Sociology, Health Services Research and Rehabilitation
Science at the University of Cologne [e.g., [26,27]]. The
scale was adapted for the ambulatory care [28] and it
measures different aspects of a trusting physician-
patient-interaction. The three items of the scale were
worded as follows: (1) “I completely trusted my doctor”,
(2) “I had the impression that the doctor is very compe-
tent”,a n d( 3 )“With the doctor one is in good hands”.
Four answer categories were given, ranging from “do
not agree at all” (=1) to “completely agree” (=4). All
items were summed and divided by the number of
items.
Sample
The subjects of the present study were patients who had
participated in the Cologne Smoking Study (CoSmoS)
and who had been randomly recruited at the University
Hospital Cologne.
The study was approved by the Ethics Committee of
the University Hospital of Cologne (UHC). Patients
were included in the study after signing an informed
consent form. The participating patients suffered from
either myocardial infarction or lung cancer or from
neither of these conditions (control group). All patients
smoked daily or on occasion up until the time of data
collection. In face-to-face interviews, the participants
were asked, in particular, about their smoking habits
and the smoking cessation counseling provided by their
GPs.
The sample was then reduced by excluding nine
patients who stated that they had not consulted a gen-
eral practitioner. This resulted in a total sample size of
127 currently smoking patients. The response “Id o n ’t
know” was treated as a missing value.
The socio-demographic and illness-specific character-
istics of our sample are presented in Table 2.
Data analysis
Confirmatory factor analysis
The Statistical Package for Social Science (SPSS) Ver-
sion 17.0 was used to compute the descriptive statistics
and to obtain both the frequency and percentage distri-
butions. The percentage of missing values for each item
did not exceed 2.5%. In order to avoid biases, missing
data were imputed using the NORM software, which
Table 2 Socio-demographic and illness-specific characteristics (n = 127)
Variable n Response trait Frequency (n) Percentage (%)
Disease 127 lung cancer 39 30.7
myocardial infarction 41 32.3
control group 47 37
Gender 121 male 78 64.5
female 43 35.5
School education with admission to higher education 30 23.6
without admission to higher education 97 76.4
Professional education 121 with a graduate degree 102 84.3
with a graduate degree 19 15.7
Age 117 *M = 54.8; Mdn = 55; SD = 9.5; Min = 35; Max = 75
Age group 117 35-45 22 18.8
46-55 42 35.9
56-65 35 29.9
66-75 18 15.4
Note: M = Mean; Mdn = Median; SD = Standard deviation; Min = Minimum; Max = Maximum
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replace missing values [29].
Confirmatory factor analysis (CFA) was conducted to
determine whether the instrument measures a unidi-
mensional construct as intended. Due to the non-nor-
mal distribution resulting from dichotomous items, the
analysis was conducted using tetrachoric correlations
[30]. In addition, robust weighted least squares with the
mean- and variance-adjusted c
2 algorithm were applied
using Mplus Version 4.2 [31].
CFA assumes that each manifest variable is a distinct
indicator of an underlying latent construct. A CFA
model is evaluated using measures of global and local
fit. Such measures indicate whether the proposed model
adequately reproduces the empirical correlations among
the manifest variables [23].
For several of the recommended global fit measures,
certain criteria must be met in order to accept the
model as being plausible and parsimonious. Measures of
absolute fit, such as the root mean square error of
approximation (RMSEA), can be interpreted as the
amount of information within the empirical covariance
matrix that cannot be explained by the proposed model.
The model may be classified as acceptable if only 8% or
less of the information is not accounted for by the
model (RMSEA < 0.08). Other goodness-of-fit indica-
tors, including the comparative fit index (CFI) and the
Tucker-Lewis index (TLI), were also examined. Hair et
al. [23] suggest using adjusted index cut-off values based
on model characteristics. They maintain that simple
models and small samples should be subject to stricter
evaluation than more complex models with larger sam-
ples. Based on their recommendations, we used a sam-
ple size of N < 250, a number of observed variables ≤
1 2 ,aC F Ia n daT L Io f0 . 9 7o rb e t t e r ,a n daR M S E A<
0.08.
The process of psychometric evaluation also involves
testing the reliability of measurement and assessing the
quality of the individual items, both of which are evalu-
ated using component fit results (e.g., factor loadings,
composite reliability, average variance extracted and
indicator reliability) from the confirmatory factor analy-
sis. Measures of local fit evaluate whether each con-
struct can be reliably estimated from its indicators [23].
The factor loadings - recommended to be at a value of
0.5 or higher - indicate how much of the variance in an
item is explained by the latent factor. In addition, it is
crucial to examine the reliability of the proposed model,
especially its composite reliability, for which 0.6 is an
acceptable value. The average variance extracted (AVE)
is a summary measure of convergence among the items.
Its recommended acceptable threshold is ≥ 0.5. Indicator
reliability should be greater than 0.3 in order to guaran-
tee a stable estimate [23].
Discriminant validity
In addition to CFA, we tried to examine construct valid-
ity with further analysis. In the context of the present
study it was possible to test the discriminant validity of
the “SmoCess-GP” instrument as one form of construct
validation [32]. Therefore, the relationship with the
patients’ trust in their GPs was analyzed. We used
bivariate analysis (Pearson’s correlation) with the mean
sum score of the “SmoCess-GP” instrument and the
mean sum score of the “trust in physicians_short form”
scale. A weak association was expected between both
constructs because of assumed distal relationships
between those constructs.
The SPSS Version 17.0 for Windows software was
used to conduct the analysis for construct validity.
Results
Descriptive findings
The descriptive statistics for each item of the “SmoCess-
GP” instrument is shown in Table 1. As a whole, not all
participants had been screened by their physicians to
determine the extent of their smoking habits. In fact,
there is a noticeable decrease in the percentage of smo-
kers in all disease groups, who received physician-deliv-
ered interventions as of item 4. This means that only a
small proportion of smokers were offered special smok-
ing cessation interventions, such as being recommended
a smoking cessation course (item 4), being provided
with advice on quitting (item 5) or being prescribed a
nicotine replacement therapy (item 6). The mean of
approximately 2.3 (range: 0-6: 0 = no intervention at all,
6 = all 6 interventions; median = 2; standard deviation =
1.58) indicates that the number of smoking cessation
interventions offered by GPs is, as a whole, small and
that patients were unable to obtain concrete assistance
and support.
In addition, the descriptive findings of the “trust in
physicians_short form” scale, which is used for examin-
ing the discriminant validity of the “SmoCess-GP” mea-
sure, are presented in Table 3.
Confirmatory factor analysis
CFA of the “SmoCess-GP” measure found that the same
unidimensional structure of the six items was replicated
as in the exploratory factor analysis in our pilot study
[20]. To quantify the differences between observed and
estimated covariance matrices [23], the chi-square value
was calculated. With c
2
df = 6 = 4.63 and a nonsignificant
p-value of 0.59, a very good model fit was obtained [23].
The model, therefore, adequately accounts for the infor-
mation in the empirical covariance matrix. In addition,
the global fit indices, such as the CFI with a value of
1.00 and the TLI with a value of 1.02, show very good
values. The root mean square error of approximation
(RMSEA) of 0.00 indicates that 0% of the information is
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strates the excellent fit of our model. The results of the
analysis can be found in Table 4.
Examination of the factor loadings reveals that all six
items have significant loadings on the construct in the
model and exceed the threshold of ≥ 0.50 as recom-
mended (see Table 5). All six indicator reliabilities with
values higher than 0.30 (see Table 5) exceed the accep-
t a b l ev a l u e s[ 2 3 ] .T h es a m ei st r u ef o rt h ec o m p o s i t e
reliability (0.86) and the average variance extracted
(AVE = 0.50).
Discriminant validity
In terms of discriminant validity of the “SmoCess-GP”
instrument, the bivariate analysis with the “trust in phy-
sicians_short form” scale resulted in a correlation of r =
0.092; p = 0.350.
Discussion
We developed a short instrument within the context of
the Cologne Smoking Study (CoSmoS) for assessing the
extent of smoking cessation interventions provided by
GPs as seen from the patients’ perspective. The present
study evaluated the psychometric quality of the “Smo-
Cess-GP” measure using confirmatory factor analysis
(CFA) in order to analyze its unidimensional structure.
T h ea n a l y s i si n d i c a t e dav e r yg o o dm o d e lf i t .B o t ht h e
resulting chi-square value with a non-significant p-value
as well as the CFI, TLI and RMSEA values provide evi-
dence of an adequate global data fit. The local fit indices
support the explicitness of the “SmoCess-GP” instru-
ment, and the indicator reliabilities prove that the items
reliably measure the construct. Acceptable factor loading
values, composite reliability and the average variance
extracted confirm the quality and reliability of the mea-
sure and its items. As confirmed by all of the goodness-
of-fit indices, it was possible to replicate the unidimen-
sionality of the instrument.
In terms of discriminant validity, the results of the
bivariate analysis confirmed the initial hypothesis that
there is only a weak relationship between the patients’
trust in their GPs and the provision of smoking cessa-
tion counseling by them.
Our findings can therefore be seen as preliminary
indicators of the construct validity of the “SmoCess-GP”
instrument which has to be further evaluated using
other forms and methods of validation.
The descriptive findings - in specific, the mean sum
score - of the “SmoCess-GP” instrument indicate a lack
of preventive care in German general practices because
not every smoking patient in our sample received anti-
smoking advice from their GPs and because several dif-
ferent concrete intervention options were seldom
offered. However, these results are not unique to Ger-
many. Other international studies have reported similar
findings [12,15-18], and the lack of preventive care has
often been explained by structural barriers, such as
reimbursement [e.g., [33]], the medical setting or train-
ing [e.g., [34]].
Limitations of the study
Several limitations of the present study have to be men-
tioned. First of all, given the retrospective design of the
study and the hospital setting, there may be a bias
caused by distortions in the patients’ memory. Although
participants were asked to think of their general practi-
tioner when responding to statements, it is not known
exactly which physician and which consultation experi-
ences the patients were actually remembering when
being surveyed. Furthermore, in view of the findings of
Houston et al. [35], which indicated that delayed mea-
sures of provider performance from the patients’ per-
spective, like the HEDIS, may result in an over- or
under-estimation, we can not exclude that the “Smo-
Cess-GP” instrument also suffers from this limitation. In
this regard, a possible over-reporting of smoking
Table 3 Descriptive statistics of the “trust in physicians_short form” (TRIP_sf) scale
Item Missing value M SD Min Max
1. I completely trusted my doctor 6 3.52 0.856 1 4
2. I had the impression that the doctor is very competent 6 3.50 0.845 1 4
3. With the doctor one is in good hands 6 3.50 0.845 1 4
TRIP_sf 6 3.50 0.793 1 4
Note: The participants were asked to respond with regards to the practitioner they contact first if they have a health problem (e.g., their general practitioner).
Answer categories ranging from “do not agree at all” (=1) to “completely agree” (=4).
M = Mean; SD = Standard deviation; Min = Minimum; Max = Maximum
Table 4 Measures of global fit
c
2
df df p TLI CFI RMSEA
Thresholds for acceptable fit >.05 >0.97 >0.97 <0.08
CFA model 4.63 6 0.59 1.02 1.00 0.00
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caused by the wording of the “SmoCess-GP” instrument,
which asks for provided counseling in general, without a
specific time-frame of consultations. A more time-speci-
fic query will certainly lead to different patient responses
and should be tested in comparative studies.
Second, the face-to-face interview method may also
h a v eb e e nas o u r c eo fb i a s .A ni n t e r v i e w e ra n do t h e r
patients in the hospital room may have prompted parti-
cipants to provide false or socially desirable responses.
Third, the convergent validity of the “SmoCess-GP”
instrument could not be tested against similar measures
because a comparable instrument had not been inte-
grated in the CoSmoS questionnaire.
The generalizability of our findings is limited because
the sample was inpatient and thus no conclusions for
the population can be drawn.
Future research
Future research should evaluate the instrument psycho-
metrically in prospective studies with a population-
based sample. In addition, the convergent validity should
be tested with similar smoking cessation intervention
measures like for example the Health Plan Employer
Data and Information Set (HEDIS) measure “Medical
Assistance with Smoking Cessation” [24]. Also concur-
rent validity can be evaluated with observation studies
or studies in which consultations are audio taped. Audio
taping is regarded as a more objectively assessment of
the physicians behavior than patients surveys [36,37].
Thus, the results of our study must be interpreted with
caution, because an over- or under-reporting can not be
excluded so far. On the other hand there are several
other studies which have examined the concurrent
validity of physicians’ behavior and patients’ recall. For
example, the results of Ward and Sanson-Fisher [38]
indicated a high sensitivity (92%) and a somewhat lower
specificity (82%) of patients’ recall of inter alia smoking
cessation advices by a post-graduated trainee. Stange et
al. [37] evaluated the validity of non-observational meth-
ods, such as patient questionnaires for assessing inter
alia smoking cessation counseling services with
observational methods. Findings showed an acceptable
accuracy (sensitivity of 72% and specificity of 96%) of
the patients exit surveys. The observations of smoking
counseling activities by physicians in the survey of Eller-
beck et al. [39] showed good correlations with the
patients’ recall on this topic. Wilson and Mc Donald
[36] found an acceptable sensitivity (81.8%) in estimat-
ing smoking cessation counseling for smoking patients
by patient questionnaires compared with the detection
on audio tape. The rate of false positive answers was
10.5%. The authors conclude, that “ap a t i e n tq u e s t i o n -
naire may be the most feasible method of assessing in
large scale research or audit studies whether advice on
lifestyle...has been given.” [[36], p.1485]. Moreover, a
valid correlation with the assessment of smoking cessa-
tion interventions from the GPs’ perspective would pro-
vide additional evidence for criterion validity.
Following the practice guideline of the U.S. Depart-
ment of Health and Human Service, smoking cessation
interventions should be adapted to the smoker’s stage of
readiness [40]. Therefore, the third item “My practi-
tioner empathically demanded me to quit smoking”
should be modified for further studies towards a more
motivational than demanding meaning. This should be
carried out on the basis of the recommendation of the
guideline which points out, that in case of patients
unwilling to quit Motivational Interviewing (MI) “...is
more effective than clinician exhortations, lectures, or
arguments for quitting..."[[40], p.57].
In the present study, we did not ask about how often
the smoking cessation counseling was provided. This
c o u l db eo fi n t e r e s ti nt h i sc o n t e x ta n ds h o u l db ec o n -
sidered in further development of the instrument.
Conclusion
Our aim was to develop a measure, which describes and
evaluates the smoking cessation interventions in general
practice. Despite the study’s limitations and require-
ments of valuable improvements of the instrument, the
findings indicate reasonable results in terms of the preli-
minary validity and reliability of the new “SmoCess-GP”
instrument. As a patient-reported measure, it provides
researchers and GPs an instrument that makes it possi-
ble to analyze the extent of smoking cessation interven-
tions in general practices.
Practice implications
Although the GP plays a major role in preventive care,
t h ec h a n g eo fu n h e a l t h yb e h a vior is often considered
to be a matter of personal choice [11]. Despite evi-
dence for the effectiveness of smoking cessation inter-
ventions provided by GPs [12-14], their full potential
has not yet been exploited [12,15-18]. For this reason,
more support should be given to the preventive activ-
ities of GPs.
Table 5 Factor loadings and indicator reliabilities
Item Factor loadings Indicator
reliabilities
Thresholds for acceptable
values
(>0.5) (>0.3)
1* 0.71 0.50
2 0.78 0.62
3 0.78 0.61
4 0.77 0.59
5 0.58 0.33
6 0.63 0.40
*The wording of the items is shown in Table 1
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GP” m e a s u r e( s e ea l s o[ 2 0 ] )p r o v i d e sau s e f u lt o o lf o r
research as well as a timesaving checklist for guiding
GPs through smoking cessation counseling. As such, the
instrument can be used for GP self-audit and to help to
identify gaps in interventions. The “SmoCess-GP”
instrument also seems appropriate for use by other
healthcare professionals (e.g., specialized physicians or
nurses).
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